James & Wells’ large and experienced team leads the way in life sciences patents.
Our attorneys are at the forefront of shaping intellectual property law in this area. We combine years of experience with creative, fresh thinking, to design intellectual property strategies that are fully aligned to commercial goals.
Our dedicated Life Sciences Team is consistently regarded as the leading choice for intellectual property services by research institutes, universities, biotechnology and pharmaceutical companies, and some of Australia and New Zealand’s most innovative start-ups and scale-ups.
We have provided the intellectual property foundation on which numerous life science companies have been built, and are proud to have supported many of them through to successful IPO, acquisition, and expansion.
Technical expertise
Our life sciences specialists have extensive experience in the following areas:
- Immunology
- Antibodies and variants
- Vaccine technology
- Bacteriotherapy and probiotics
- Cell-based therapies
- Gene cloning and expression
- Gene mutations
- Gene therapy
- Genetic engineering
- RNA interference
- Personalised medicine
- Feed safety
- Food/DNA tracing
- Pharmaceutical compositions
- Cell signalling and signal transduction
- Molecular Biology
- Fusion proteins
- Nucleic acid drugs
- Drug delivery technologies
- Diagnostics and detection methods
- Markers and molecular bases of diseases
- Agriculture and plant biology
- Animal diet
- Animal treatments
- Agrichemicals
Core Life Sciences team
With advanced degrees in a diverse range of biotech areas, the patent attorneys in our Life Sciences Team understand the business and science driving their clients.
Life sciences memberships
In order to keep abreast of industry trends and be at the forefront of life sciences innovation, James & Wells is an active member of AusBiotech, Life Sciences Queensland, Biotech New Zealand and Natural Health Products NZ.
Our Head of Biotechnology, Dr Andrew Clarke sits on the AusBiotech Intellectual Property Expert Panel, which provides expertise on intellectual property issues in relation to medical devices and diagnostics, pharmaceuticals and therapeutics.
In addition, Andrew is on the biotechnology standing committee of The International Association for the Protection of Intellectual Property (AIPPI).
If we can assist you or your clients in any way, please contact us today.
